Pages that link to "Q67452785"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetic analysis of the disposition of intravenous theophylline in young children (Q67452785):
Displaying 50 items.
- Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children (Q33998916) (← links)
- An approach to the treatment of asthma (Q34051706) (← links)
- Impaired theophylline clearance in patients with cor pulmonale (Q34517450) (← links)
- Metabolism and Pharmacokinetics of Theophylline in Human Neonates, Children, and Adults (Q34708564) (← links)
- Theophylline pharmacokinetics in premature infants with apnea (Q34724159) (← links)
- Pharmacokinetic observations of phenytoin disposition in the newborn and young infant (Q34985675) (← links)
- Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation (Q35825168) (← links)
- Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs (Q35827012) (← links)
- Aminophylline Dosage In Asthma Exacerbations in Children: A Systematic Review (Q36092457) (← links)
- Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood. (Q38756077) (← links)
- Drug level monitoring in paediatric practice (Q38914642) (← links)
- Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models (Q39283612) (← links)
- The management of status asthmaticus in infants and children (Q39493179) (← links)
- Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring (Q39525952) (← links)
- Theophylline poisoning. Pharmacological considerations and clinical management (Q39749509) (← links)
- Clinical Pharmacokinetics of Theophylline (Q39758588) (← links)
- Influence of Cigarette Smoking on Drug Metabolism in Man (Q39808606) (← links)
- Single-Entity Sustained Theophylline Therapy for the Pre-School Child (Q40119421) (← links)
- Theophylline A “State of the Art” Review (Q40150067) (← links)
- A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products (Q40174727) (← links)
- Hypothesis for the Individualisation of Drug Dosage (Q41031782) (← links)
- Intrapatient variability in theophylline kinetics (Q41510935) (← links)
- Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies (Q41540238) (← links)
- Maturation of caffeine elimination in infancy (Q42096312) (← links)
- Pharmacokinetics of sufentanil in normal children (Q43614968) (← links)
- Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates (Q43633475) (← links)
- Effect of exchange transfusion on elimination of theophylline in premature neonates (Q43718979) (← links)
- Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways (Q43735635) (← links)
- Pharmacokinetics of theophylline in infants with bronchiolitis (Q43837936) (← links)
- Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibility (Q43839435) (← links)
- Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status (Q46234808) (← links)
- Relationships between plasma theophylline clearance, liver volume and body weight in children and adults (Q47258929) (← links)
- Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children. (Q50181827) (← links)
- Determination of theophylline clearance in South African children (Q51050930) (← links)
- Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials (Q51796989) (← links)
- Development and evaluation of a generic physiologically based pharmacokinetic model for children (Q51933198) (← links)
- A mechanistic approach for the scaling of clearance in children (Q52013911) (← links)
- Altered clearance of theophylline in children with Down syndrome: a case series. (Q52177999) (← links)
- Pharmacokinetics of theophylline in young children with asthma: Comparison of rectal enema and suppositories (Q66959776) (← links)
- Urinary excretion of methylated purines in man and in the rat after the administration of theophylline (Q67030423) (← links)
- Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion (Q67356624) (← links)
- Urinary caffeine metabolites in man. Age-dependent changes and pattern in various clinical situations (Q67575640) (← links)
- Comparison of the in vitro dissolution properties and in vivo steady-state pharmacokinetics of two sustained-release theophylline preparations (Q68299472) (← links)
- Dyphylline Prodrugs: Plasma Hydrolysis and Dyphylline Release in Rabbits (Q68330465) (← links)
- Effect of miocamycin on theophylline kinetics in children (Q68816886) (← links)
- Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility (Q68853863) (← links)
- Intraindividual changes in theophylline clearance during constant aminophylline infusion in children with acute asthma (Q69519275) (← links)
- Neonatal pharmacology--a practical approach (Q69619198) (← links)
- Risks of theophylline therapy in asthma (Q70691688) (← links)
- Pharmacologic considerations in the therapy of neonatal apnea (Q70704714) (← links)